Sienna Biopharmaceuticals Overview
- Founded
- 2010
- Status
- Public
- Employees
- 39
- Stock Symbol
- SNNAQ
- Investments
- 1
Sienna Biopharmaceuticals General Information
Description
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.
Contact Information
Website
Formerly Known As
Sienna Labs
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
PINX
Primary Office
- 30699 Russell Ranch Road
- Suite 140
- Westlake Village, CA 91362
- United States
+1 (818) 000-0000
Sienna Biopharmaceuticals Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $232K | 79.8K |
Sienna Biopharmaceuticals Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 | FY 2016 31-Dec-2016 |
|---|---|---|---|---|
| EV | (13,007) | 15,053 | 287,833 | |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (52,417) | (73,314) | (50,715) | (21,095) |
| Net Income | (47,951) | (73,471) | (50,545) | (21,162) |
| Total Assets | 43,492 | 107,306 | 136,847 | 62,377 |
| Total Debt | 0 | 30,125 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Sienna Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Sienna Biopharmaceuticals‘s full profile, request access.
Request a free trialSienna Biopharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is available in the PitchBook Platform. To explore Sienna Biopharmaceuticals‘s full profile, request access.
Request a free trialSienna Biopharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechno
Pharmaceuticals
Westlake Village, CA
39
As of 2019
00000
0000000000.
0000000
agna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex e
0000 000000000
San Diego, CA
00
As of 0000
000.00
0000000000 0
000.00
000000 0
ehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cu
000000000000000
San Diego, CA
000
As of 0000
000.00
000000000
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSienna Biopharmaceuticals Competitors (7)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dermata | Venture Capital-Backed | San Diego, CA | 00 | 000.00 | 0000000000 0 | 000.00 |
| 000000 000000 | Corporate Backed or Acquired | San Diego, CA | 000 | 000.00 | 000000000 | 000.00 |
| 000000 0000000 | Venture Capital-Backed | San Diego, CA | 000 | 00000 | 000000 - 000 | 00000 |
| 0000000 0000000000 | Private Equity-Backed | Pune, India | 000 | 000.00 | 000000000 | 000.00 |
| 000000 00000000000 | Venture Capital-Backed | Carlsbad, CA | 0 | 000.00 | 00000000000 | 000.00 |
Sienna Biopharmaceuticals Executive Team (18)
Sienna Biopharmaceuticals Board Members (15)
| Name | Representing | Role | Since |
|---|---|---|---|
| Dennis Fenton Ph.D | Self | Board Member | 000 0000 |
| Donna Janson | Self | Board Member | 000 0000 |
| Erle Mast | Self | Board Member | 000 0000 |
| Frederick Beddingfield III | Sienna Biopharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |
| James Hindman | Self | Board Member | 000 0000 |
Sienna Biopharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSienna Biopharmaceuticals Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 | 06-Dec-2016 | 000000000000000000 | 00000 | Biotechnology |